# MNCs

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/mncs
Canonical HTML page: https://getbiobrief.com/entity/mncs

## Timeline

- **2026-03-20**: Capital Pivot — Major foreign venture funds announce new China-specific high-tech and biotech investment vehicles.
- **2026-03-18**: Official Roadmap Launch — China formally unveils the five-year roadmap focusing on New Quality Productive Forces.
- **2025-11-15**: Policy Drafting — Preliminary drafts of the 15th Five-Year Plan signal a shift toward high-tech self-reliance.

## Recent coverage (1 stories)

### Foreign Capital Pivots to China's Biotech Sector Under New Five-Year Roadmap
2026-03-18 13:14:06 · Sentiment: Positive · Impact: 7/10 · Sources: 3

China's launch of its 15th Five-Year Roadmap has triggered a strategic shift in foreign investment toward high-tech sectors, with biotechnology emerging as a primary beneficiary. Global pharmaceutical giants and venture funds are recalibrating their portfolios to align with Beijing’s 'New Quality Productive Forces' initiative.
Full story: https://getbiobrief.com/story/china-biotech-five-year-roadmap-foreign-capital

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.